user-generated· price
Pharma stocks underperform S&P 500 by 5% over next 6 months
Investor uncertainty about FDA approval timelines and leadership will lead to underperformance in biotech and pharma stocks. The sector will lag broader market benchmarks.
price · Prediction Market
- Implied probability (Yes)
- 60%
More price markets
- Samsung Electronics market cap to exceed $1.2T by Q3 2026 — 78% Yes
- Cisco stock to rise above $65 by Q3 2026 — 72% Yes
- Private jet charter prices increase 20% in 2027 — 75% Yes
- Google Messages sees 30% user growth in 6 months post-launch — 70% Yes
- US AI chip ETF doubles in value by 2026-09-30 — 65% Yes
- X’s stock price rises 10% within 3 months of History tab launch — 55% Yes
- TSK enters top 5 Spanish engineering firms by market cap — 60% Yes
- Ford stock volatility exceeds 60% annualized within 6 months — 75% Yes
Loading…